Prosecution Insights
Last updated: May 29, 2026

Tsubota Laboratory, Inc.

6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (67%)
0
Easy (0%)
2
Unknown (33%)

Rejection Statute Mix

BucketCases
§103 only3 (50%)
§102 only1 (17%)
No statute on record2 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
17% of docket
2
Mechanical / Eng
33% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JONES, JAMES 1 88.5% +4.3%
VAJDA, KRISTIN ANN 1 84.1% +10.6%
RZECZYCKI, PHILLIP MATTHEW 1 57.4% +45.0%
BELL, SARA ELIZABETH 1 73.5% +39.9%
EISEMAN, LYNSEY C 1 49.0% +39.4%
ALLEN, ROBERT F 1 74.2% +60.3%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18561634 OPHTHALMIC PREPARATION FOR MYOPIA SUPPRESSION VAJDA, KRISTIN ANN 9d
18564751 Eyewear and Cartridge JONES, JAMES 60d

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18026232 DEVICE AND METHOD FOR INHIBITING CHOROIDAL THINNING EISEMAN, LYNSEY C 42d overdue
16982152 NON-INVASIVE CORNEA AND SCLERA STRENGTHENING DEVICE AND METHOD ALLEN, ROBERT F 35d overdue
18266102 Eyedrops for Inhibiting Myopia Progression in Children and Screening Method for Inhibitor of Myopia Progression in Children BELL, SARA ELIZABETH 30d overdue
18561634 OPHTHALMIC PREPARATION FOR MYOPIA SUPPRESSION VAJDA, KRISTIN ANN 9d
18266103 Eyedrops for Treating Scleral Thinning and Screening Method for Therapeutic Agent of Scleral Thinning RZECZYCKI, PHILLIP MATTHEW 9d

Top Art Units

Art UnitApps
1625 2
2872 1
1622 1
3796 1
3783 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18564751 Eyewear and Cartridge JONES, JAMES 2872 §102 Non-Final OA 60d Pending Nov 28, 2023
18561634 OPHTHALMIC PREPARATION FOR MYOPIA SUPPRESSION VAJDA, KRISTIN ANN 1622 §103 Non-Final OA 9d Pending Nov 16, 2023
18266103 Eyedrops for Treating Scleral Thinning and Screening Method for Therapeutic Agent of Scleral Thinning RZECZYCKI, PHILLIP MATTHEW 1625 Other Non-Final OA 9d Pending Jun 08, 2023
18266102 Eyedrops for Inhibiting Myopia Progression in Children and Screening Method for Inhibitor of Myopia Progression in Children BELL, SARA ELIZABETH 1625 Other Non-Final OA 30d overdue Pending Jun 08, 2023
18026232 DEVICE AND METHOD FOR INHIBITING CHOROIDAL THINNING EISEMAN, LYNSEY C 3796 §103 Final Rejection 42d overdue Pending Mar 14, 2023
16982152 NON-INVASIVE CORNEA AND SCLERA STRENGTHENING DEVICE AND METHOD ALLEN, ROBERT F 3783 §103 Final Rejection 35d overdue Pending Sep 18, 2020

Managing Tsubota Laboratory, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month